Skip to content

Viking Therapeutics VKTX Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATX logo
GATXGATX
$1.75M+243%
CarGurus, Inc. logo
CarGurus, Inc.CARG
-$613K-186%
Seaboard logo
SeaboardSEB
$0-100%
SPS Commerce logo
SPS CommerceSPSC
$288K-56.4%
HTF
Heartflow, Inc. Common StockHTFL
26,200,000%+17,776,022pp
Repligen logo
RepligenRGEN
-$145K-104%

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$4.04B+38.7%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
Viking Therapeutics (VKTX) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of $16K in Q1 2026.
How has Viking Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
Viking Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash increased by 1500.0% year-over-year, from $1K to $16K.